freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Cancer patients missing out on effective treatment on the NHS

Published on 24/04/2012

Cancer patients may be missing out on the most effective treatments on the NHS because of poor access to new biomarker tests, according to a new survey.

100 oncologists took part in an online survey sponsored by drug company Merck Serono. 75 per cent of these said they had to overcome barriers to be able to use targeted medicines on their patients.

Biomarker tests identify patients with particular genetic make-ups

The majority of the specialists agreed that access to biomarker tests for personalised medicines was subject to a postcode lottery.

Biomarker tests can identify patients with particular genetic make-ups or blood proteins that make them suitable for specific therapies. Lung, breast, bowel cancers and leukaemia are the key diseases where personalised medicines are available.

Merck Serono announced last year that it would fully fund the KRAS biomarker testing for all UK patients diagnosed with bowel cancer.

However, 53 per cent of the consultants who took part in the online poll said they ‘often or sometimes’ prescribed a treatment that was not necessarily the best choice for an individual patient because of access to tests.

Breast cancer treatment Herceptin, for instance, is only effective for women with an over-active Her2 gene, and antibody drug cetuximab only works for around 60 per cent of patients with bowel cancer.

22 per cent of the oncologists said patients were sometimes given drugs without reference to test results that could indicate whether the treatment would work.

The doctors said the cost and red tape in the NHS were the main obstacles to biomarker tests. They also highlighted the long delays in obtaining the test results from specialist laboratories.

More than a fifth said they would be more likely to offer personalised medicine to a private patient or those with private medical insurance.

Dr Tim Iveson, consultant medical oncologist at Southampton General Hospital and a member of the charity Bowel Cancer UK's medical board, said: "These findings are extremely worrying. It is simply not acceptable that some patients are not getting the treatment that they deserve.”

Health Minister Lord Howe said has promised a new commissioning and funding structure which will come into effect next year and improve access to biomarker tests on the NHS.

© ActiveQuote Ltd. 2012

Categories:  MedicalNHS and Hospitals
Cancer patients missing out on effective treatment on the NHS Cancer patients may be missing out on the most effective treatments on the NHS because of poor access to new biomarker tests, according to    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

Proactive, efficient, and offered me insurance I need. I would say half price I would end up paying if I did it by myself. Many thanks.

Review centre member

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...